270 related articles for article (PubMed ID: 12604529)
1. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Sep; 44(9):2242-6. PubMed ID: 10952562
[TBL] [Abstract][Full Text] [Related]
4. Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.
Caughlan RE; Sriram S; Daigle DM; Woods AL; Buco J; Peterson RL; Dzink-Fox J; Walker S; Dean CR
Antimicrob Agents Chemother; 2009 Dec; 53(12):5015-21. PubMed ID: 19786597
[TBL] [Abstract][Full Text] [Related]
5. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
[TBL] [Abstract][Full Text] [Related]
7. Knock-out of multidrug efflux pump MexXY-OprM results in increased susceptibility to antimicrobial peptides in Pseudomonas aeruginosa.
Neidig A; Strempel N; Waeber NB; Nizer WSDC; Overhage J
Microbiol Immunol; 2023 Sep; 67(9):422-427. PubMed ID: 37424105
[TBL] [Abstract][Full Text] [Related]
8. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
Srikumar R; Kon T; Gotoh N; Poole K
Antimicrob Agents Chemother; 1998 Jan; 42(1):65-71. PubMed ID: 9449262
[TBL] [Abstract][Full Text] [Related]
9. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.
Llanes C; Hocquet D; Vogne C; Benali-Baitich D; Neuwirth C; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1797-802. PubMed ID: 15105137
[TBL] [Abstract][Full Text] [Related]
10. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
11. Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa.
Okamoto K; Gotoh N; Nishino T
Antimicrob Agents Chemother; 2002 Aug; 46(8):2696-9. PubMed ID: 12121960
[TBL] [Abstract][Full Text] [Related]
12. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
14. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
[TBL] [Abstract][Full Text] [Related]
18. MexXY RND pump of
Singh M; Sykes EME; Li Y; Kumar A
Microbiology (Reading); 2020 Nov; 166(11):1095-1106. PubMed ID: 32909933
[TBL] [Abstract][Full Text] [Related]
19. Association of carbapenem and multidrug resistance with the expression of efflux pump-encoding genes in Pseudomonas aeruginosa clinical isolates.
Yousefi S; Nazari M; Ramazanzadeh R; Sahebkar A; Safarzadeh E; Khademi F
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):161-166. PubMed ID: 37227802
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa.
Caughlan RE; Jones AK; Delucia AM; Woods AL; Xie L; Ma B; Barnes SW; Walker JR; Sprague ER; Yang X; Dean CR
Antimicrob Agents Chemother; 2012 Jan; 56(1):17-27. PubMed ID: 22024823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
